| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer
1 company
Mainolfi Nello is a Chief Executive Officer at Kymera Therapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 37 sells.
Estimated insider holdings value: $56.5M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 29, 2026 | KYMR Kymera Therapeutics, Inc. | Chief Executive Officer | Sale+OE | 30,000 | $81.18 | $2,435,377.20 | -1.5% | - | - | |
| Dec 31, 2025 | KYMR Kymera Therapeutics, Inc. | Chief Executive Officer | Sale+OE | 30,000 | $78.06 | $2,341,939.35 | -2.2% | +7.0% | - | |
| Dec 8, 2025 | KYMR Kymera Therapeutics, Inc. | Chief Executive Officer | Sale+OE | 100,000 | $89.17 | $8,917,000.00 | -13.1% | -9.8% | - | |
| Oct 29, 2025 | KYMR Kymera Therapeutics, Inc. | Chief Executive Officer | Sale+OE | 30,000 | $60.99 | $1,829,736.91 | -1.5% | +20.2% | - | |
| Sep 16, 2025 | KYMR Kymera Therapeutics, Inc. | Chief Executive Officer | Sale+OE | 30,000 | $49.00 | $1,470,000.00 | -4.3% | +75.6% | - | |
| Jun 3, 2025 | KYMR Kymera Therapeutics, Inc. | Chief Executive Officer | Sale+OE | 30,000 | $49.00 | $1,470,000.00 | -4.3% | -6.6% | - | |
| Jan 12, 2022 | KYMR Kymera Therapeutics, Inc. | Chief Executive Officer | Sale+OE | 48,000 | $53.31 | $2,558,742.25 | -0.9% | -28.1% | -33.8% | |
| Oct 11, 2021 | KYMR Kymera Therapeutics, Inc. | Chief Executive Officer | Sale+OE | 48,000 | $56.34 | $2,704,536.28 | -1.3% | +3.4% | -62.2% | |
| Aug 4, 2021 | KYMR Kymera Therapeutics, Inc. | Chief Executive Officer | Sale+OE | 6,706 | $60.06 | $402,786.30 | -0.7% | +7.0% | -53.8% | |
| Aug 2, 2021 | KYMR Kymera Therapeutics, Inc. | Chief Executive Officer | Sale+OE | 30,415 | $60.25 | $1,832,370.60 | -1.3% | +5.8% | -61.8% |